Skip to content

Duccio Papanti

10 papers in the library · 423 citations · publishing 2013-2020

Papers

Sort Most recent Most cited

How does ayahuasca work from a psychiatric perspective? Pros and cons of the entheogenic therapy.

Human Psychopharmacology: Clinical and Experimental May 1, 2020 Laura Orsolini, Stefania Chiappini, Duccio Papanti et al. 27 citations

Ayahuasca is a hallucinogenic plant preparation, traditionally consumed in sacred ceremonies by indigenous North-Westerner Amazonian countries like Colombia, Peru, Brazil, and Ecuador. It is fundamental to carefully balance benefits/risks related to the ayahuasca intake, both during ceremonies and experimental settings. The aim is at evaluating and comparing the potential therapeutic benefits...

The Bridge Between Classical and “Synthetic”/Chemical Psychoses: Towards a Clinical, Psychopathological, and Therapeutic Perspective

Frontiers in Psychiatry November 20, 2019 Laura Orsolini, Stefania Chiappini, Duccio Papanti et al. 41 citations

The critical spread and dissemination of novel psychoactive substances (NPS), particularly among the most vulnerable youngsters, may pose a further concern about the psychotic trajectories related to the intake of new synthetic drugs. The psychopathological pattern of the "new psychoses" appears to be extremely different from the classical presentation. Therefore, clinicians need more data on...

DOI: 10.3389/fpsyt.2019.00851 (opens in new tab) Addiction Psychopathology Synthetic cannabinoids Perspective graphical +3

Psychedelic Fauna for Psychonaut Hunters: A Mini-Review

Frontiers in Psychiatry May 22, 2018 Laura Orsolini, Michela Ciccarese, Duccio Papanti et al. 25 citations

Currently different classes of psychoactive substances are easily available for abuse, including several hundred novel psychoactive substances (NPS). Some of these drugs occur naturally in plants and animals or are chemically modified from plant or animal compounds and have been abused by humans over millennia. Recently, the occurrence of a new "drug culture" (e.g., psychonauts) who consume a...

Synthetic Cannabinoids: Psychopharmacology, Clinical Aspects, Psychotic Onset

CNS & Neurological Disorders - Drug Targets April 17, 2017 Giovanni Martinotti, Rita Santacroce, Duccio Papanti et al. 62 citations

BACKGROUND: Synthetic Cannabinoids (SC) are the widest and most diffused class of Novel Psychoactive Substances. The short- and long- term health risks associated with the consumption of SC are often unknown to both users and health professionals. This review aims to provide a synthesis of the most recent and relevant insights on the pharmacology, clinical and psychopathological aspects of SC....

DOI: 10.2174/1871527316666170413101839 (opens in new tab) Cannabis Synthetic cannabinoids Scopus Psychopathology +1

NPS: Medical Consequences Associated with Their Intake.

Current Topics in Behavioral Neurosciences 2017 Fabrizio Schifano, Laura Orsolini, Duccio Papanti et al.

Over the last decade, the 'traditional' drug scene has been supplemented - but not replaced - by the emergence of a range of novel psychoactive substances (NPS), which are either newly created or existing drugs, including medications, now being used in novel ways. By the end of 2014, in excess of 500 NPS had been reported by a large number of countries in the world. Most recent data show,...

DOI: 10.1007/7854_2016_15 (opens in new tab) Full text (opens in new tab) Drug misuse Hallucinogenic drugs Hallucinogens Novel psychoactive substances +4

Evolutionary Considerations on the Emerging Subculture of the E-psychonauts and the Novel Psychoactive Substances: A Comeback to the Shamanism?

Current Neuropharmacology December 2, 2016 Laura Orsolini, Paul St John‐smith, Daniel Mcqueen et al. 28 citations

Indeed, a range of evolutionary mechanisms, such as: optimal foraging, costly signaling, and reproduction at the expense of health may all cooperate to explain the recent spread and diffusion of the NPS market, and this may represent a reason of concern.

DOI: 10.2174/1570159x15666161111114838 (opens in new tab) Shamanism Psychoactive substance Mechanism biology Subculture biology +1

The “Endless Trip”: Psychopathology and psychopharmacology in the Hallucinogen Persisting Perception Disorder (HPPD)

European Psychiatry March 1, 2016 Laura Orsolini, Alessandro Valchera, Duccio Papanti et al. 3 citations

Introduction Hallucinogen Persisting Perception Disorder (HPPD) is a syndrome characterized by prolonged or reoccurring perceptual symptoms, reminiscent of acute hallucinogen effects. HPPD was associated with a broader range of LSD (lysergic acid diethylamide)-like substances, including cannabis, MDMA (methylenedioxymethamphetamine), psilocybin, mescaline and other psychostimulants....

Venlafaxine as the ‘baby ecstasy’? Literature overview and analysis of web‐based misusers′ experiences

Human Psychopharmacology: Clinical and Experimental July 1, 2015 Giulia Francesconi, Laura Orsolini, Duccio Papanti et al. 22 citations

INTRODUCTION: Venlafaxine is one of the most frequently prescribed antidepressants worldwide, despite its toxicity risk in overdose. Furthermore, the molecule has been recently identified at the EU-wide level as one of the novel psychoactive substances. This paper aims at investigating the potential of misuse, taking into account both the existing literature and the analysis of the misusers'...

“Noids” in a nutshell: everything you (don’t) want to know about synthetic cannabimimetics

Advances in Dual Diagnosis August 12, 2014 Duccio Papanti, Laura Orsolini, Giulia Francesconi et al. 24 citations

Purpose – “Spice” products are synthetic cannabimimetics (SC; also called “synthetic cannabinoids”)-based designer drugs used as a legal alternative to cannabis for their very strong tetrahydrocannabinol (THC)-like effects. The purpose of this paper is to provide an analysis of more recent clinical and pharmacology/toxicology findings relating to SC and describe how they could impact on health,...

DOI: 10.1108/add-02-2014-0006 (opens in new tab) Cannabis Anxiety Synthetic cannabinoids Cannabinoid receptor +3

“Spiceophrenia”: a systematic overview of “Spice”‐related psychopathological issues and a case report

Human Psychopharmacology: Clinical and Experimental July 1, 2013 Duccio Papanti, Fabrizio Schifano, Giulia Botteon et al. 191 citations

OBJECTIVES: The use of synthetic cannabimimetics (SC; "spice" drugs) is increasing, especially among teenagers and young adults. In parallel with this, the number of studies describing intoxication episodes associated with psychotic symptoms in SC users is growing. We present both a systematic review of the related literature and a case report, which seems to highlight the existence of a...

DOI: 10.1002/hup.2312 (opens in new tab) Psychosis Exacerbation Psychopathology Synthetic cannabinoids +1